Progressive Maculopathy After Discontinuation of Pentosan Polysulfate Sodium

Ophthalmic Surgery Lasers and Imaging Retina - Tập 50 Số 10 - Trang 656-659 - 2019
Rachel M. Huckfeldt, Demetrios G. Vavvas

Tóm tắt

A pigmentary maculopathy associated with chronic use of the drug pentosan polysulfate sodium (PPS) was recently described. The authors present a case of PPS-associated maculopathy that continued to progress for 6 years after discontinuation of this medication. [ Ophthalmic Surg Lasers Imaging Retina . 2019;50:656–659.]

Từ khóa


Tài liệu tham khảo

10.1016/j.ophtha.2018.04.026

10.1016/j.juro.2018.02.011

10.1038/gim.2014.172

10.1016/S0022-5347(17)50948-9

Teichman JM. The role of pentosan polysulfate in treatment approaches for interstitial cystitis. Rev Urol. 2002;4 Suppl 1:S21–27.

10.1016/j.juro.2015.01.086

Documentation related to New Drug Application 020193 to the United States Food and Drug Administration. U.S. Food and Drug Administration website. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm. Accessed February 19 2019.

10.1016/j.juro.2014.09.036

10.1097/IAE.0000000000002408

10.1111/j.1755-3768.2008.01359.x

Thông tin
Thông tin xuất bản

Ophthalmic Surgery Lasers and Imaging Retina

Tập 50 Số 10

656-659

Thông tin tác giả